Latest filing published 02 Dec 2014 for Aevi Genomic Medicine, LLC, €8,040.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stephen D. Mcmurray: trading record in brief
Stephen D. Mcmurray appears in our data through filings on Aevi Genomic Medicine, LLC shares, published by SEC (Form 4). The record holds 8 filings, for trades running from 13 April 2011 to 1 December 2014.
In open-market terms, that means 1 purchase worth €8,040 on one side and 1 sale worth €109k on the other. Netting one side against the other leaves €101k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants and 1 option exercise. 2014 to date brings 1 purchase and no sales.
On 2 December 2014 came the latest disclosure, an open-market purchase for €8,040 in Aevi Genomic Medicine, LLC. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen D. Mcmurray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,439 shares@ US$4.10Common StockSEC:0001144204-14-071761:0Canonical exit: 1 Mar 2015 (T+90)
- 7,000 shares0Common StockSEC:0001144204-14-000760:0
- 7,000 shares0Common StockSEC:0001144204-13-001707:0
- 10,935 shares@ US$12.50Common StockSEC:0001144204-12-048413:0
- 33,052 shares@ US$7.35Common StockSEC:0001144204-12-047418:0
- 22,117 shares@ US$10.98Common StockSEC:0001144204-12-047418:1
- 7,000 shares0Common StockSEC:0001144204-12-011445:0
- 1,840 sharesCommon StockSEC:0001144204-11-021917:0
8 of 8 declarations